Off-Target Lapatinib Activity Sensitizes Colon Cancer Cells Through TRAIL Death Receptor Up-Regulation
Science Translational Medicine - United States
doi 10.1126/scitranslmed.3001384
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 8, 2011
Authors
Publisher
American Association for the Advancement of Science (AAAS)